comparemela.com

Latest Breaking News On - Aligos therapeutics - Page 9 : comparemela.com

Earnings Scheduled For August 3, 2023 - Myriad Genetics (NASDAQ:MYGN), PLAYSTUDIOS (NASDAQ:MYPS)

Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is likely to report quarterly earnings at $1.10 per share on revenue of $512.74 million.

New-jersey
United-states
Brookfield
Canada
Red-rock
Ontario
Diamondrock
Northwest-territories
Blackrock
Nova-scotia
Canadian
Abcellera-biologics

Aligos Therapeutics to Announce Second Quarter Results on August 03, 2023

Aligos Therapeutics to Announce Second Quarter Results on August 03, 2023
itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.

Veronica-eames
Corey-davis
Exchange-commission-on
Aligos-therapeutics-inc
Lifesci-communications
Nasdaq
Exchange-commission
Aligos-therapeutics
Securities-litigation-reform-act
Aligo-quarterly-report

Aligos Therapeutics Presents Data from its Liver Disease Programs at the European Association for the Study of the Liver (EASL) Congress 2023

Aligos Therapeutics Presents Data from its Liver Disease Programs at the European Association for the Study of the Liver (EASL) Congress 2023
itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.

Vienna
Wien
Austria
Ukraine
Russia
Jin-hong
Corey-davis
Yannick-debing
Lawrence-blatt
Alina-jucov
Kusum-gupta
Jinlin-hou

Aligos Therapeutics to Present Data on its Liver Disease Programs at the European Association for the Study of the Liver (EASL) Congress 2023

SOUTH SAN FRANCISCO, Calif., June 07, 2023 Aligos Therapeutics, Inc. , a clinical stage biopharmaceutical company focused on developing novel therapeutics to address unmet medical needs in liver. | June 7, 2023

Ukraine
Vienna
Wien
Austria
Russia
Alina-jucov
Yannick-debing
Jinlin-hou
Veronica-eames
Corey-davis
Kusum-gupta
Tongfei-wu

Aligos Therapeutics Xiamen Amoytop Biotech the treatment of liver diseases (NASDAQ:ALGS)

Clinical stage biopharmaceutical company focused on developing novel therapeutics to address unmet medical needs in liver and viral diseases, Aligos Therapeutics (ALGS) enters research.

China
Aligos-therapeutics
Xiamen-amoytop-biotech
Greater-china

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.